Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hutzen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
BMC Cancer|April 1, 2009
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cellsLing Cen, Brian Hutzen, Sarah Ball, et al.
BMC Cancer|October 23, 2008
STAT3 can be activated through paracrine signaling in breast epithelial cellsJacqueline C Lieblein, Sarah Ball, Brian Hutzen, et al.
Molecular Cancer|October 23, 2008
Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survivalChun-Liang Chen, Ling Cen, Jennifer Kohout, et al.
Molecular Therapy Oncolytics|October 17, 2017
TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of RhabdomyosarcomaBrian Hutzen, Chun-Yu Chen, Pin-Yi Wang, et al.
Cancer Science|June 30, 2009
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cellsLi Lin, Brian Hutzen, Sarah Ball, et al.
Scientific Reports|May 26, 2017
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma ModelsChun-Yu Chen, Pin-Yi Wang, Brian Hutzen, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cellsLi Lin, Brian Hutzen, Pui-Kai Li, et al.
Plos One|December 31, 2013
Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cellsLi Lin, Brian Hutzen, Hsiu-Fang Lee, et al.
Cancer Research|March 11, 2010
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cellsLi Lin, Brian Hutzen, Mingxin Zuo, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BMC Cancer|April 1, 2009
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cellsLing Cen, Brian Hutzen, Sarah Ball, et al.
BMC Cancer|October 23, 2008
STAT3 can be activated through paracrine signaling in breast epithelial cellsJacqueline C Lieblein, Sarah Ball, Brian Hutzen, et al.
Molecular Cancer|October 23, 2008
Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survivalChun-Liang Chen, Ling Cen, Jennifer Kohout, et al.
Molecular Therapy Oncolytics|October 17, 2017
TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of RhabdomyosarcomaBrian Hutzen, Chun-Yu Chen, Pin-Yi Wang, et al.
Cancer Science|June 30, 2009
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cellsLi Lin, Brian Hutzen, Sarah Ball, et al.
Scientific Reports|May 26, 2017
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma ModelsChun-Yu Chen, Pin-Yi Wang, Brian Hutzen, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cellsLi Lin, Brian Hutzen, Pui-Kai Li, et al.
Plos One|December 31, 2013
Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cellsLi Lin, Brian Hutzen, Hsiu-Fang Lee, et al.
Cancer Research|March 11, 2010
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cellsLi Lin, Brian Hutzen, Mingxin Zuo, et al.
Pageof 3